Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity
Authors
Keywords
-
Journal
MOLECULES AND CELLS
Volume 32, Issue 3, Pages 209-220
Publisher
Springer Nature
Online
2011-08-01
DOI
10.1007/s10059-011-0126-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
- (2010) K. V. Gleixner et al. CANCER RESEARCH
- Polo-box domain: a versatile mediator of polo-like kinase function
- (2010) Jung-Eun Park et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors
- (2010) Italo Beria et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Probing Binding Modes of Small Molecule Inhibitors to the Polo-Box Domain of Human Polo-like Kinase 1
- (2010) Chenzhong Liao et al. ACS Medicinal Chemistry Letters
- Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
- (2009) Kyle A. Emmitte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors
- (2009) Yoshiyuki Sato et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Distinct Concentration-Dependent Effects of the Polo-like Kinase 1-Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis
- (2009) A. G. Gilmartin et al. CANCER RESEARCH
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- A Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis
- (2009) Wolfgang Reindl et al. CHEMBIOCHEM
- Identification and Validation of a Potent Type II Inhibitor of Inactive Polo-like Kinase 1
- (2009) Sarah Keppner et al. ChemMedChem
- BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
- (2009) D. Rudolph et al. CLINICAL CANCER RESEARCH
- Polo-like kinases: conservation and divergence in their functions and regulation
- (2009) Vincent Archambault et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
- (2009) Sang-Moon Yun et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
- (2009) S. Sur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors
- (2008) Emily J. Hanan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors
- (2008) Raymond V. Fucini et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of Polo-like Kinase 1 by Blocking Polo-Box Domain-Dependent Protein-Protein Interactions
- (2008) Wolfgang Reindl et al. CHEMISTRY & BIOLOGY
- Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and development
- (2008) Tohru Takaki et al. CURRENT OPINION IN CELL BIOLOGY
- Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1
- (2008) Mark Petronczki et al. DEVELOPMENTAL CELL
- 36 ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours
- (2008) P. Schöffski et al. EJC SUPPLEMENTS
- Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors
- (2008) Klaus Mross et al. JOURNAL OF CLINICAL ONCOLOGY
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now